A Study of BL-B01D1 Combined With Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

NCT06986785 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: BL-B01D1
DRUG: Lenvatinib

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]